Drugs / PF-06743649
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02187029 | Jul → Dec 2014 | gout | Pfizer | Terminated | Met primary |
| Phase 1 | NCT02170012 | Jul → Sep 2014 | — | Pfizer | Terminated | No outcome recorded |
| Phase 1 | NCT02151617 | Jun → Dec 2014 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06743649 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02151617 ↗ |
| Route | Oral | “multiple oral doses of PF-06743649” NCT02151617 ↗ |